Clinical trials

  • Interferon alfa | Ciclosporin A | Interleukin-1 | Interleukin-2 | Ribonucleic acid | Specific nucleic acid SNA-HLA II | Specific nucleic acid SNA-PAPI for Human papillomavirus infection | High-risk HPV genital infection
  • INFIGRATINIB for Achondroplasia
  • XALURITAMIG for Metastatic castration-resistant prostate cancer
  • EFGARTIGIMOD ALFA for Generalized myasthenia gravis
  • NIPOCALIMAB for Sjögren's disease | Sjögren's syndrome
  • AMIVANTAMAB for Colorectal cancer | KRAS/NRAS and BRAF wild-type colorectal cancer
  • alpha-1-proteinase inhibitor (human) for Pulmonary emphysema due to alpha-1 antitrypsin deficiency
  • AMIVANTAMAB for Left-sided colorectal cancer (KRAS/NRAS and BRAF wild-type)
  • FLUNARIZINE HYDROCHLORIDE for Migraine
  • ozanimod for Relapsing-remitting multiple sclerosis
  • RITUXIMAB for B-cell acute lymphoblastic leukaemia (childhood)|B precursor acute lymphoblastic leukaemia (Bcp-ALL)
  • DORNASE ALFA for Pleural empyema